158 related articles for article (PubMed ID: 38256932)
1. Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway.
Zhao J; Liang G; Yang J; Huang H; Dou Y; Gu Z; Liu J; Zeng L; Yang W
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256932
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis.
Liu MM; Dong R; Hua Z; Lv NN; Ma Y; Huang GC; Cheng J; Xu HY
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32914833
[TBL] [Abstract][Full Text] [Related]
3. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis.
Xia B; Xu B; Sun Y; Xiao L; Pan J; Jin H; Tong P
J Ethnopharmacol; 2014 Apr; 153(1):133-41. PubMed ID: 24530448
[TBL] [Abstract][Full Text] [Related]
4. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.
Liang G; Zhao J; Pan J; Yang Y; Dou Y; Yang W; Zeng L; Liu J
J Orthop Surg Res; 2023 Apr; 18(1):312. PubMed ID: 37087476
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis.
Wang Q; Huang P; Xia C; Fu D
Medicine (Baltimore); 2022 Nov; 101(47):e31387. PubMed ID: 36451445
[TBL] [Abstract][Full Text] [Related]
7. Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.
Wu Z; Zhu Z; Cao J; Wu W; Hu S; Deng C; Xie Q; Huang X; You C
Medicine (Baltimore); 2022 Nov; 101(46):e31711. PubMed ID: 36401375
[TBL] [Abstract][Full Text] [Related]
8. The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1.
Guo W; Yang XG; Shi YL; Wang H
J Orthop Surg Res; 2022 Feb; 17(1):90. PubMed ID: 35164817
[TBL] [Abstract][Full Text] [Related]
9. Let-7b downgrades CCND1 to repress osteogenic proliferation and differentiation of MC3T3-E1 cells: An implication in osteoporosis.
Wang LJ; Cai HQ
Kaohsiung J Med Sci; 2020 Oct; 36(10):775-785. PubMed ID: 32533643
[TBL] [Abstract][Full Text] [Related]
10. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
11. A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.
He D; Huang JH; Zhang ZY; Du Q; Peng WJ; Yu R; Zhang SF; Zhang SH; Qin YH
Drug Des Devel Ther; 2019; 13():3989-4005. PubMed ID: 31819371
[TBL] [Abstract][Full Text] [Related]
12. Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis.
Huang X; Li S; Lu W; Xiong L
BMC Endocr Disord; 2022 Jul; 22(1):189. PubMed ID: 35869471
[TBL] [Abstract][Full Text] [Related]
13. A network pharmacological-based study of the mechanism of Liuwei Dihuang pill in the treatment of chronic kidney disease.
Xie X; Lou H; Shi Y; Gan G; Deng H; Ma X; Meng M; Gao X
Medicine (Baltimore); 2023 May; 102(19):e33727. PubMed ID: 37171332
[TBL] [Abstract][Full Text] [Related]
14. [
Ruan H; She D; Sun S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):1998-2005. PubMed ID: 38189384
[TBL] [Abstract][Full Text] [Related]
15. Protection of Icariin Against Hydrogen Peroxide-Induced MC3T3-E1 Cell Oxidative Damage.
Sun JB; Wang Z; An WJ
Orthop Surg; 2021 Apr; 13(2):632-640. PubMed ID: 33619876
[TBL] [Abstract][Full Text] [Related]
16. MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway.
Zou L; Xiang C; Lu M
Mol Biotechnol; 2023 Jul; 65(7):1085-1095. PubMed ID: 36443618
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Pretreatment with Quercetin Against Lipopolysaccharide-Induced Apoptosis and the Inhibition of Osteoblast Differentiation via the MAPK and Wnt/β-Catenin Pathways in MC3T3-E1 Cells.
Guo C; Yang RJ; Jang K; Zhou XL; Liu YZ
Cell Physiol Biochem; 2017; 43(4):1547-1561. PubMed ID: 29035884
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of resveratrol promoting differentiation of preosteoblastic MC3T3-E1 cells based on network pharmacology and experimental validation.
He Y; Liu F; He M; Long F; Hu D; Chen J; Fang M; Wang Z
BMC Complement Med Ther; 2024 Feb; 24(1):108. PubMed ID: 38424533
[TBL] [Abstract][Full Text] [Related]
19. Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology.
Zhu F; Li W; Wang L; Dai B; Liu Z; Wu H; Deng T
J Orthop Surg Res; 2023 Jan; 18(1):21. PubMed ID: 36624462
[TBL] [Abstract][Full Text] [Related]
20. High water-soluble curcuminoids-rich extract regulates osteogenic differentiation of MC3T3-E1 cells: Involvement of Wnt/β-catenin and BMP signaling pathway.
Pengjam Y; Syazwani N; Inchai J; Numit A; Yodthong T; Pitakpornpreecha T; Panichayupakaranant P
Chin Herb Med; 2021 Oct; 13(4):534-540. PubMed ID: 36119369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
